Amedeo Smart

Free Medical Literature Service


 

Amedeo

Peptic Ulcer

  Free Subscription

Articles published in
J Gastroenterol
    February 2024
  1. HUANG Y, Lu H
    Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial.
    J Gastroenterol. 2024 Feb 14. doi: 10.1007/s00535-024-02085.
    >> Share

    January 2024
  2. LEECH T, Peiris M
    Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis.
    J Gastroenterol. 2024 Jan 14. doi: 10.1007/s00535-023-02065.
    >> Share

    December 2023
  3. ICHITA C, Goto T, Shimizu S
    Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data.
    J Gastroenterol. 2023 Dec 19. doi: 10.1007/s00535-023-02066.
    >> Share

  4. UENO M, Fujiwara T, Tokumasu H, Mizuno M, et al
    Reply to "Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data".
    J Gastroenterol. 2023 Dec 13. doi: 10.1007/s00535-023-02067.
    >> Share

    November 2023
  5. KAWAGUCHI T, Okamoto K, Fujimoto S, Bando M, et al
    Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway.
    J Gastroenterol. 2023 Nov 22. doi: 10.1007/s00535-023-02052.
    >> Share

    October 2023
  6. KOTANI S, Shibagaki K, Hirahara N, Hasegawa N, et al
    Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naive patients: a multicenter retrospective analysis.
    J Gastroenterol. 2023 Oct 19. doi: 10.1007/s00535-023-02050.
    >> Share

  7. HAN YY, Zhou L, Hu YL, Ding XW, et al
    Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study.
    J Gastroenterol. 2023 Oct 1. doi: 10.1007/s00535-023-02042.
    >> Share

    July 2023
  8. WATANABE K, Iijima K
    Risk of pneumonia associated with proton pump inhibitor use.
    J Gastroenterol. 2023 Jul 16. doi: 10.1007/s00535-023-02022.
    >> Share

    June 2023
  9. HIRAI R, Hirai M, Otsuka M, Mitsuhashi T, et al
    Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program.
    J Gastroenterol. 2023 Jun 21. doi: 10.1007/s00535-023-02010.
    >> Share

  10. MARET-OUDA J, Panula J, Santoni G, Xie S, et al
    Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.
    J Gastroenterol. 2023 Jun 14. doi: 10.1007/s00535-023-02007.
    >> Share

    May 2023
  11. UENO M, Fujiwara T, Tokumasu H, Mano T, et al
    Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan.
    J Gastroenterol. 2023 May 12. doi: 10.1007/s00535-023-02000.
    >> Share

    April 2023
  12. HUANG Y, Chen J, Ding Z, Chen X, et al
    Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial.
    J Gastroenterol. 2023 Apr 12. doi: 10.1007/s00535-023-01991.
    >> Share

  13. KATO M, Hosoe N, Gotoda T, Kusano C, et al
    Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study.
    J Gastroenterol. 2023;58:358-366.
    >> Share

    December 2022
  14. KAKIUCHI T, Matsuo M, Endo H, Sakata Y, et al
    Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study.
    J Gastroenterol. 2022 Dec 17. doi: 10.1007/s00535-022-01942.
    >> Share

  15. WALDUM H
    Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy.
    J Gastroenterol. 2022 Dec 17. doi: 10.1007/s00535-022-01943.
    >> Share

  16. HOLMBERG D, Lagergren J
    Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.
    J Gastroenterol. 2022 Dec 14. doi: 10.1007/s00535-022-01941.
    >> Share

    October 2022
  17. SONG L, Song M, Rabkin CS, Chung Y, et al
    Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia.
    J Gastroenterol. 2022 Oct 27. pii: 10.1007/s00535-022-01933.
    >> Share

  18. HOLMBERG D, Mattsson F, Xie S, Ness-Jensen E, et al
    Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.
    J Gastroenterol. 2022 Oct 18. pii: 10.1007/s00535-022-01930.
    >> Share

    August 2022
  19. AKAZAWA Y, Ueyama H, Hayashi T, Utsunomiya H, et al
    Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma.
    J Gastroenterol. 2022 Aug 8. pii: 10.1007/s00535-022-01906.
    >> Share

    June 2022
  20. ITO M, Sugiyama A, Mino M, Kodama M, et al
    Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study.
    J Gastroenterol. 2022 Jun 20. pii: 10.1007/s00535-022-01885.
    >> Share

    February 2022
  21. IWAKIRI K, Fujiwara Y, Manabe N, Ihara E, et al
    Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.
    J Gastroenterol. 2022 Feb 28. pii: 10.1007/s00535-022-01861.
    >> Share

    August 2021
  22. FUKUCHI T, Hirasawa K, Sato C, Makazu M, et al
    Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors.
    J Gastroenterol. 2021 Aug 23. pii: 10.1007/s00535-021-01815.
    >> Share

    June 2021
  23. MATSUHASHI T, Hatta W, Hikichi T, Fukuda S, et al
    A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding.
    J Gastroenterol. 2021 Jun 18. pii: 10.1007/s00535-021-01797.
    >> Share

    February 2021
  24. KAMADA T, Satoh K, Itoh T, Ito M, et al
    Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
    J Gastroenterol. 2021 Feb 23. pii: 10.1007/s00535-021-01769.
    >> Share

  25. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.
    >> Share

  26. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.
    >> Share

    November 2020
  27. IBANEZ-SANZ G, Mila N, de la Pena-Negro LC, Garcia M, et al
    Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.
    J Gastroenterol. 2020 Nov 7. pii: 10.1007/s00535-020-01738.
    >> Share

  28. ROGERS B, Samanta S, Ghobadi K, Patel A, et al
    Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
    J Gastroenterol. 2020 Nov 5. pii: 10.1007/s00535-020-01743.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016